On September 16, 2026, IDEXX Laboratories announced its acquisition of CoVet. The acquisition will expand IDEXX’s veterinary software, diagnostics and AI offerings through the integration of CoVet’s ambient listening and clinical workflow technology.
IDEXX Laboratories is a Maine-based company that provides diagnostic, software and other technology products and services for veterinary practices.
CoVet is a provider of AI-powered clinical workflow software for veterinary practices. Its platform enables veterinary teams to capture and organize information across the patient care process, including consultations, clinical documentation, treatment planning and client follow-up.
Osler, Hoskin & Harcourt LLP advised CoVet with a team consisting of Gary Marshall, Mihnea Horatiu Porime, AJ Case and Emma Runzer-Boucher (Emerging and High Growth Companies); Shuli Rodal and Chelsea Rubin (Competition/Antitrust and Foreign Investment); Adam LaRoche and Erika Romanow (Privacy and Data Management); Damian Rigolo (Employment and Labour); Sam Ip (Technology); Barry Fong (Intellectual Property); and Ann Zhang (Pensions and Benefits).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Associate, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
Partner, Competition/Antitrust and Foreign Investment, Toronto
Associate, Competition, Trade and Foreign Investment, Toronto
Partner, Privacy and Data Management; Employment and Labour, Calgary
Associate, Privacy and Data Management, Calgary
Partner, Employment and Labour, Toronto
Partner, Technology, Toronto
Partner, Intellectual Property, Ottawa
Associate, Pensions and Benefits, Toronto
